What Role Do Combinations of Interferon and Targeted Agents Play in the First-Line Therapy of Metastatic Renal Cell Carcinoma?

This publication has 44 references indexed in Scilit:

• JAK/STAT signal transduction: Regulators and implication in hematological malignancies
  Biochemical Pharmacology, 2006
• Expression of RASSF1A, an Epigenetically Silenced Tumor Suppressor, Overcomes Resistance to Apoptosis Induction by Interferons
  Cancer Research, 2006
• Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy
  British Journal of Surgery, 2002
• Expression profiling of a human cell line model of prostatic cancer reveals a direct involvement of interferon signaling in prostate tumor progression
  Proceedings of the National Academy of Sciences, 2002
• Signaling through the JAK/STAT pathway, recent advances and future challenges
  Gene, 2002
• Cloning and Expression of a Long Form of the β Subunit of the Interferon αβ Receptor That Is Required for Signaling
  Journal of Biological Chemistry, 1995
• Jak-STAT Pathways and Transcriptional Activation in Response to IFNs and Other Extracellular Signaling Proteins
  Science, 1994
• Angiogenic Factors
  Science, 1987
• 125I-labelled Human Interferons Alpha, Beta and Gamma: Comparative Receptor-binding Data
  Journal of General Virology, 1985
• Evidence that types I and II interferons have different receptors
  Nature, 1981